The Peptide CommonsEst. May 2024
Search
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · UK & Ireland

NHS criteria and how they are applied in practice

Regional › UK & IrelandNHS cost per milligram personal import MHRA
AE
a.eriksenTL2 Moderator10 Jun 2026#1

NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable.

A coverage question with the paperwork detail included, since that is what determines the answer.

Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next, which is the useful thing about a well-written denial.

Before I spend a week on it: is my reading of the stated criterion correct, and is there a documented precedent for this specific ground?

0 likes 2mo
UC
unit_conversionTL3Regular12 Jun 2026#2

Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.

26 likes 1mo
RV
r.vukovicTL2 Moderator14 Jun 2026#3

On the opening post — agreed on the reasoning, with one qualification.

Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.

12 likes 1mo
TP
tracked_parcelTL2Regular16 Jun 2026#4

post #2 answers the question as asked. The question underneath it is different.

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

4 likes 1mo
AV
ai.vukovicTL2 Moderator17 Jun 2026#5

Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing.

The correction was fair and I had been repeating something I had not checked carefully enough.

0 likes 1mo
ER
eire_readerTL2Regional · IE19 Jun 2026#6
unit_conversion, post #2: Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up. Go to post

Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand your obligations.

19 likes in reply to #2 1mo
FH
f.haddadTL2 Moderator20 Jun 2026#7
a.eriksen, post #1: NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next, which… Go to post

Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.

8 likes in reply to #1 1mo
PN
p.novotnyTL2Regular21 Jun 2026#8

post #7 is right about the mechanism and I think understates the practical bit.

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

2 likes 1mo
MN
ma.nascimentoTL2 Moderator23 Jun 2026 · edited#9

Coming back to post #7, because the follow-up matters more than the original answer.

Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.

27 likes 1mo
CP
citation_peakTL3Regular24 Jun 2026#10

Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for diabetes. Private prescription at full cost is usual for weight management.

13 likes 1mo
N
NardoneTL2Member25 Jun 2026#11

Picking up post #8: that is the part I would want checked first.

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

32 likes 1mo
LV
l.vermeulenTL2 Moderator26 Jun 2026#12

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

0 likes 1mo
AK
a.kwiatkowskiTL2Member27 Jun 2026#13
tracked_parcel, post #4: post #2 answers the question as asked. The question underneath it is different. NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria. Go to post

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

3 likes in reply to #4 30d
TV
t.vargaTL2 Moderator29 Jun 2026#14

Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.

11 likes 29d
I
IRenaudinTL2Member30 Jun 2026 · edited#15

Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for diabetes. Private prescription at full cost is usual for weight management.

24 likes 28d
KO
k.ogunleyeTL2 Moderator1 Jul 2026#16

Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.

0 likes 27d
MM
methods_marginTL3Regular2 Jul 2026#17
f.haddad, post #7: Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI. Go to post

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

1 like in reply to #7 26d
SC
s.chowdhuryTL3Regular3 Jul 2026#18

Worth separating two things that post #14 runs together.

Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with UKVI.

7 likes 25d
C
CSagredoTL3Regular4 Jul 2026#19

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

0 likes 24d
HB
h.bhattacharyaTL2 Moderator5 Jul 2026#20
IRenaudin, post #15: Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for diabetes. Private prescription at full cost is usual for weight management. Go to post

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

3 likes in reply to #15 23d
EI
e.iyerTL2 Moderator6 Jul 2026 · edited#21

Coming back to post #19, because the follow-up matters more than the original answer.

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

0 likes 22d
MH
ms_hollowayTL4Mass spectrometrist7 Jul 2026#22

Occupational health screening: some UK occupations require medical checks. Disclosure of weight-loss medication might be relevant to employment screening; understand your obligations.

24 likes 21d
NS
n.silvaTL2 Moderator8 Jul 2026#23

Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and specialist service availability. Postcode determines access risk.

7 likes 20d
SL
s.leclercTL4 Moderator9 Jul 2026#24
a.eriksen, post #1: NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the answer. Denial received, with a stated reason. My reading of the reason is that it tells me exactly what to submit next, which… Go to post

post #23 answers the question as asked. The question underneath it is different.

I disagree with the reply above, and I think the disagreement is substantive rather than terminological.

The distinction being drawn does not survive when you look at the published data for this specific question. I would be glad to be shown wrong on this, because the version I am arguing against is more convenient.

1 like in reply to #1 19d
RB
r.bruunTL2 Moderator10 Jul 2026#25

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

0 likes 18d
SC
sourced_claimsTL3Regular11 Jul 2026#26

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

33 likes 17d
CC
ch.correiaTL2 Moderator12 Jul 2026#27

Worth separating two things that post #23 runs together.

Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.

11 likes 16d
DV
dr.villanuevaTL3Physician13 Jul 2026#28
tracked_parcel, post #4: post #2 answers the question as asked. The question underneath it is different. NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria. Go to post

post #27 is right about the mechanism and I think understates the practical bit.

Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for diabetes. Private prescription at full cost is usual for weight management.

3 likes in reply to #4 15d
JB
j.bhattacharyaTL2 Moderator14 Jul 2026#29

Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate. Expect to be asked for measurements and history.

25 likes 14d
SC
s.chowdhuryTL3Regular15 Jul 2026 · edited#30

Picking up post #27: that is the part I would want checked first.

NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI thresholds, or other specific criteria.

12 likes 13d
Sponsored Sigma-Aldrich — certified reference materialsReference standards, analytical reagents and certified materials for method calibration. If you are validating a method, this is where the standard comes from.Reference standards →